Study guide

38.2 Cardiovascular Medicine II: Tachyarrhythmias and Bradyarrhythmias, Atrial Fibrillation, Sudden Cardiac Death and Brugada Syndrome, Cardiac Arrest, Valvular and Rheumatic Heart Disease, Infective Endocarditis, Myocarditis and Pericardial Disease

Philippine Physician Licensure Examination Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: PLE Structure, Eligibility & Study Strategy

1.1 PLE Format, 2026 Schedule & the Statutory Passing Rule 1.2 Eligibility, Internship, PRC Filing & Test-Day Rules 1.3 Reading the 2025 Tables of Specifications & Building a Study Plan

2 Chapter 2: Physiology I: Cells, Blood, Nerve & Muscle

2.1 Homeostasis, Cell Function, Membrane Transport & Resting Potential 2.2 Blood Cells, Immunity, Hemostasis, Fibrinolysis & Blood Distribution 2.3 Action Potentials, Conduction, the Neuromuscular Junction & Muscle Contraction

3 Chapter 3: Physiology II: Cardiovascular & Respiratory Systems

3.1 Cardiac Electrophysiology, the Cardiac Cycle & the Heart as a Pump 3.2 Circulation: Resistance, Venous Return, Coronary Flow, Microcirculation & Fetal Circulation 3.3 Respiratory Mechanics, Gas Exchange, Gas Transport, Control of Breathing & Extreme Environments

4 Chapter 4: Physiology III: Gastrointestinal, Endocrine, Renal & Reproductive Systems

4.1 Gastrointestinal Physiology: Secretion, Motility, Digestion & Absorption 4.2 Endocrine Physiology: Hormone Chemistry, Axes, Calcium & Fuel Regulation 4.3 Renal Physiology, Body Fluid Balance & Acid-Base Regulation 4.4 Reproductive Physiology: Sexual Differentiation, Spermatogenesis, the Menstrual Cycle, Parturition & Lactation

5 Chapter 5: Physiology IV: Neurophysiology & Special Senses

5.1 Sensory Receptors, Somatic Sensation, Spinal Reflexes & Motor Control 5.2 Higher Brain Functions, Sleep, the Autonomic Nervous System, Cerebral Blood Flow & the Special Senses

6 Chapter 6: Legal Medicine I: Medicolegal Examination, Identification & Death

6.1 The Medicolegal Examination, Physical Evidence & the Crime Scene 6.2 Identification of the Living, the Dead & Skeletal Remains 6.3 Thanatology: Death, Brain Death, Postmortem Changes & Time of Death

7 Chapter 7: Legal Medicine II: Injuries, Sexual Crimes, Reproduction, Mental State & Poisoning

7.1 Physical Injuries: Revised Penal Code Classes, Wounds, Gunshot Injuries, Asphyxia & Burns 7.2 Sexual Crimes, Violence Against Women & Child Abuse 7.3 Medicolegal Aspects of Pregnancy, Delivery, Abortion, Infanticide, Paternity & Marriage 7.4 Disturbance of Mentality: Insanity, Intoxication, Capacity & the Mental Health Act 7.5 Forensic Toxicology & Poisoning: Diagnosis, Evidence, Antidotes & Philippine Laws

8 Chapter 8: Legal Medicine III: Reports, Regulation, Liability & Ethics

8.1 The Medicolegal Report, the Death Certificate, Autopsy Rules & Communicating with Relatives 8.2 Licensure & Regulation of Medical Practice: RA 2382, the Board of Medicine, PRC & Prescribing Laws 8.3 Medical Malpractice: Civil, Criminal & Administrative Liability and Key Philippine Doctrines 8.4 Physician Relationships Under the PMA Code of Ethics: Patients, Colleagues, Allied Health, Students, Industry, HMOs, Hospitals & PhilHealth 8.5 Bioethical Principles, Informed Consent, Confidentiality, End-of-Life & Research Ethics

9 Chapter 9: Pathology I: Cell Injury, Inflammation & Hemodynamics

9.1 Cell Injury, Adaptation, Necrosis, Apoptosis, Accumulations & Calcification 9.2 Acute & Chronic Inflammation, Granulomas, Systemic Effects & Tissue Repair 9.3 Hemodynamic Disorders: Edema, Hemorrhage, Thrombosis, Embolism, Infarction, DIC & Shock

10 Chapter 10: Pathology II: Genetics, Neoplasia, Immunity, Environment & Infection

10.1 Genetic Disorders & Neoplasia: Mendelian, Chromosomal, Non-Classic Inheritance, Tumor Biology & Markers 10.2 Immunopathology: Hypersensitivity, Autoimmunity, Immunodeficiency & Transplant Rejection 10.3 Environmental & Nutritional Pathology: Air Pollution, Tobacco, Metals, Occupational Lung Disease & Deficiency States 10.4 Pathology of Infectious Diseases: Transmission, Tissue Reaction Patterns & Diagnostic Morphology

11 Chapter 11: Pathology III: Gastrointestinal, Cardiovascular & Respiratory Pathology

11.1 Gastrointestinal, Hepatic, Biliary & Pancreatic Pathology 11.2 Cardiovascular & Collagen Pathology: Heart Failure, Congenital, Ischemic, Hypertensive, Valvular, Pericardial & Myocardial Disease 11.3 Respiratory Pathology: Atelectasis, Edema, ARDS, Obstructive & Restrictive Disease, Vascular Disease, Infections, Tumors & Pleura

12 Chapter 12: Pathology IV: Hematopoietic, Genitourinary, Endocrine & Nervous System Pathology

12.1 Hematopoietic Pathology: Anemias, Polycythemia, Bleeding Disorders, DIC & Lymphoid and Myeloid Neoplasms 12.2 Genitourinary Pathology: Glomerular, Tubulointerstitial, Vascular & Cystic Kidney Disease, Renal Tumors, Obstruction & Genital Disorders 12.3 Endocrine Pathology: Pancreas, Adrenal, Parathyroid, Thyroid & Pituitary Disorders 12.4 Nervous System Pathology: Cerebrovascular Disease, Edema & Herniation, Infections, Degenerative & Demyelinating Disease, Tumors

13 Chapter 13: Biochemistry I: Carbohydrate, Protein, Genetic & Energy Biochemistry

13.1 Carbohydrate Chemistry, Digestion, Glycolysis, Pyruvate Dehydrogenase & the Pentose Phosphate Pathway 13.2 Gluconeogenesis, Glycogen, Lipogenesis, Ketogenesis & Hormonal Control of Fuel Metabolism 13.3 Protein Digestion, Amino Acid Catabolism, the Urea Cycle, Heme Synthesis, Porphyrias & Bilirubin Metabolism 13.4 Amino Acids & Proteins: Structure, Properties, Separation, Specialized Products, Collagen & Protein Misfolding in Alzheimer Disease 13.5 Molecular Genetics & Enzymes: Replication, Repair, Gene Expression, Molecular Techniques, Lysosomal Storage Diseases & Enzyme Kinetics 13.6 Bioenergetics, the Citric Acid Cycle, Oxidative Phosphorylation, Muscle Energetics & Nucleotide Metabolism

14 Chapter 14: Biochemistry II: Respiratory, Nutritional, Immunologic & Cardiovascular Biochemistry

14.1 Respiratory Biochemistry: Hemoglobin, Oxygen Binding, Hemoglobinopathies, Thalassemias, Methemoglobin, Buffers & Acid-Base Balance 14.2 Nutrition Biochemistry: Dietary Standards (RENI to PDRI 2015), Food Guides, Protein Quality, Energy Expenditure, Breast Milk, Vitamins, Minerals & Blood Components 14.3 Immunology: Innate & Adaptive Immunity, the Immune Response, Antibodies, Complement, Cytokines & MHC 14.4 Cardiovascular Biochemistry: Cholesterol, Lipoproteins, Dyslipidemias, Atherogenesis, Myocardial Energetics, Biomarkers & Heart Failure

15 Chapter 15: Anatomy I: Thorax, Abdomen, Pelvis & Back

15.1 Thorax: Thoracic Wall, Breast, Pleura & Lungs, Mediastinum, Heart & Great Vessels 15.2 Abdomen: Abdominal Wall & Inguinal Region, Peritoneum, Viscera, Diaphragm & Posterior Abdominal Wall 15.3 Pelvis & Perineum: Bony Pelvis, Pelvic Floor, Pelvic Viscera, Vessels & Nerves, Perineal Pouches & the Anal Canal 15.4 Back & Spinal Column: Vertebrae, Curvatures, Joints, Back Muscles, Spinal Cord, Meninges & Cord Syndromes

16 Chapter 16: Anatomy II: Upper Limb, Lower Limb & Skin

16.1 Upper Limb: Bones, Superficial Veins, Shoulder Muscles, Axilla & Brachial Plexus, Arm, Cubital Fossa, Forearm, Hand & Joints 16.2 Lower Limb: Bones, Venous & Lymphatic Drainage, Thigh, Gluteal Region, Popliteal Fossa, Leg Compartments, Foot, Joints & Gait 16.3 Skin & Appendages: Epidermis, Junctions, Dermis, Subcutaneous Tissue, Fascia, Nerves, Vessels, Lymphatics, Hair, Nails & Glands

17 Chapter 17: Anatomy III: Head, Neck & Histology

17.1 Head I: Skull & Cranial Foramina, Scalp, Face & Parotid, Orbit, Temporal & Infratemporal Fossae, TMJ, Oral Region, Nose & Ear 17.2 Head II: Meninges & Dural Venous Sinuses, Brain Regions & Ventricles, Blood Supply, Cranial Nerves, Pituitary & Pineal, Brainstem Syndromes 17.3 Neck: Cervical Vertebrae & Hyoid, Fascial Layers, Superficial Muscles, Triangles, Root of the Neck, Visceral Layers & Lymphatics 17.4 Histology: Cells, Epithelium & Glands, Connective Tissue & Fat, Cartilage & Bone, Blood & Hematopoiesis, Muscle, Nerve, Vessels, Lymphoid Organs & Organ Histology

18 Chapter 18: Microbiology I: Foundations, Respiratory & Cardiovascular Infections

18.1 Microbiology Foundations: The Organ-System TOS, Specimens & Stains, Gram-Positive and Gram-Negative Bacteria 18.2 Respiratory Infections: Tonsillitis, Sinusitis & Mastoiditis, Bronchitis, Community-Acquired & Severe Pneumonia, Bronchiectasis and Paragonimiasis 18.3 Tuberculosis, Leprosy & Nontuberculous Mycobacteria: Pathogenesis, Diagnosis, NTP Regimens & Prevention 18.4 Cardiovascular Infections: Infective Endocarditis, Rheumatic Fever & Rheumatic Heart Disease, Myocarditis, Pericarditis and Septic Thrombophlebitis

19 Chapter 19: Microbiology II: Gastrointestinal & Nervous System Infections

19.1 Gastrointestinal Infections I: Gastroenteritis & Enterocolitis, Cholera, Typhoid & Salmonellosis, Shigellosis, Food Poisoning and Viral Hepatitis 19.2 Gastrointestinal Infections II: Amebiasis, Giardiasis & Cryptosporidiosis, Soil-Transmitted Helminths, Pinworm, Capillariasis and Tapeworms 19.3 Nervous System Infections: Meningitis & CSF Patterns, Encephalitis, Rabies and DOH PEP, Spinal Cord Infections, Tetanus & Botulism, Paralytic Shellfish Poisoning

20 Chapter 20: Microbiology III: Genitourinary, Reproductive, Blood & Skin Infections

20.1 Genitourinary Infections: Cystitis & Pyelonephritis, Urine Diagnostics, Urethritis, Balanoposthitis, Pelvic Inflammatory Disease and Genital Ulcers 20.2 Reproductive Tract Infections & STIs: Syphilis, Genital & Neonatal Herpes, HPV, Molluscum, CMV, Trichomoniasis & Vaginitis, Cervicitis, Prostatitis and Orchitis 20.3 Hematopoietic & Lymphatic Infections: Dengue and Other Hemorrhagic Fevers, Malaria, Lymphatic Filariasis, Lymphogranuloma Venereum and Epstein-Barr Virus 20.4 Integumentary Infections: Viral Exanthems (Measles, Mumps, Rubella, Varicella, Smallpox & Mpox, Fifth Disease), Herpesviruses, Fungal Skin Infections and Tick-Borne Diseases

21 Chapter 21: Microbiology IV: Musculoskeletal & Multisystemic Infections

21.1 Musculoskeletal & Soft-Tissue Infections: Osteomyelitis, Septic & Reactive Arthritis, Pyomyositis & Gas Gangrene, Cellulitis, Necrotizing Fasciitis and Bite Wounds 21.2 Multisystemic Infections I: Septicemia, Septicopyemia & Septic Shock, Leptospirosis and Schistosomiasis japonica 21.3 Multisystemic Infections II: HIV/AIDS Virology, the Philippine Epidemic & RA 11166, Diagnosis (rHIVda), ART, Prevention and Opportunistic Infections including Toxoplasmosis

22 Chapter 22: Obstetrics I: Prenatal Care, Labor & Obstetric Bleeding

22.1 Prenatal Care: Diagnosis of Pregnancy, Maternal Physiology, Dating, Nutrition & Supplements, Screening Tests and the DOH Antenatal Package 22.2 Labor & Parturition: Signs of Labor, Pelvis and Passenger, Stages and Cardinal Movements, Partograph, Fetal Monitoring, Dystocia, Shoulder Dystocia, Operative Delivery, Preterm Labor, PROM and Adolescent Pregnancy 22.3 Early Pregnancy Risks & Bleeding: Hyperemesis, Spontaneous Abortion, Recurrent Loss & Cervical Insufficiency, Ectopic Pregnancy, Hydatidiform Mole & Gestational Trophoblastic Neoplasia 22.4 Hemorrhagic Complications of Pregnancy: Placenta Previa, Abruption, Vasa Previa, Placenta Accreta Spectrum, Uterine Rupture, Third-Stage Management and Postpartum Hemorrhage

23 Chapter 23: Obstetrics II: Fetal, Hypertensive, Medical, Infectious & Postpartum Problems

23.1 Fetal Complications: Malpresentation & Breech, Macrosomia, Fetal Growth Restriction, Amniotic Fluid Disorders, Antepartum Surveillance, Rh Alloimmunization, Multiple Gestation and Post-Term Pregnancy 23.2 Hypertension & Diabetes in Pregnancy: Classification, Preeclampsia Pathogenesis and Prevention, Severe Features, Eclampsia & HELLP, Magnesium Sulfate, Gestational and Pregestational Diabetes 23.3 Medical & Surgical Disorders in Pregnancy: Drug Pharmacokinetics, Epilepsy, Thyroid, Heart Disease, SLE & APS, Asthma, Liver Disorders, Anemia, Dermatoses, Appendicitis, Gallstones, Stones and Trauma 23.4 Perinatal Infections: Triple Elimination (HIV, Syphilis, Hepatitis B), Group B Streptococcus, Chorioamnionitis, Gonorrhea & Chlamydia, Condyloma, Herpes and the TORCH Infections 23.5 Postpartum Care & Complications: Normal Puerperium, Postnatal Visits, Breastfeeding, Puerperal Fever and Infection, Mastitis, Late Hemorrhage, Mood Disorders, VTE and Postpartum Contraception

24 Chapter 24: Gynecology I: Benign Disorders, Infections & Contraception

24.1 Benign Lower Genital Tract Disorders & Pelvic Floor: Vulvar Dermatoses, Bartholin Cysts, Vaginal and Cervical Lesions, Premalignant Lesions, Pelvic Organ Prolapse, Urinary Incontinence and Fistula 24.2 Benign Upper Genital Tract Disorders: Leiomyoma, Adenomyosis & Endometriosis, Endometrial Polyps and Hyperplasia, Functional Cysts and Benign Ovarian Tumors, Adnexal Torsion and Tubal Disease 24.3 Infections of the Female Reproductive Tract: Burden & Screening, Syndromic Management, Vaginitis and Cervicitis, Pelvic Inflammatory Disease & Tubo-Ovarian Abscess, Genital Tuberculosis and Toxic Shock 24.4 Contraception & Family Planning: The RH Law, Effectiveness, Natural and Barrier Methods, Hormonal Methods, IUDs, Permanent Methods, Emergency Contraception and the WHO Eligibility Criteria

25 Chapter 25: Gynecology II: Reproductive Endocrinology, Oncology & Special Issues

25.1 Reproductive Endocrinology & Menstrual Disorders: The Menstrual Cycle, Puberty, Abnormal Uterine Bleeding (PALM-COEIN), Amenorrhea, PCOS, Hyperprolactinemia, Dysmenorrhea, Infertility, Menopause, HRT and Osteoporosis 25.2 Gynecologic Oncology: Cervical Cancer Screening, Staging & Treatment, Endometrial Cancer and Lynch Syndrome, Ovarian Tumors and BRCA, Vulvar and Vaginal Cancer, Survival and Quality of Life 25.3 Contemporary Issues & Pediatric and Adolescent Gynecology: Violence Against Women, Sexual Assault Care, Breast Disorders, Ethics of Maternal-Fetal Conflict, and Gynecologic Problems of Children and Adolescents

26 Chapter 26: Pediatrics I: Newborn, Growth, Nutrition, Immunization & Infections

26.1 The Newborn: Normal Findings and Variants, EINC (Unang Yakap), APGAR, Neonatal Resuscitation, Routine Care & Newborn Screening, Jaundice, Respiratory Distress, Hypoglycemia and Neonatal Sepsis 26.2 Growth, Development & Nutrition: Growth Parameters, Milestones and Red Flags, Speech Delay, Autism, ADHD & Global Delay, Breastfeeding and Feeding, Micronutrient Deficiencies, Malnutrition and Obesity 26.3 Immunization: RA 10152 and the National Immunization Program Schedule, Fully Immunized Child, School-Based Immunization, Other Recommended Vaccines, Vaccine Types, Cold Chain, Contraindications and AEFI 26.4 Pediatric Infectious Diseases: Bacterial (Diphtheria to Congenital Syphilis), Childhood TB, Viral Exanthems and Infections, Dengue in Children, Pediatric HIV, Protozoal, Helminthic and Fungal Infections

27 Chapter 27: Pediatrics II: Respiratory, Cardiovascular, Neurologic & Gastrointestinal Disorders

27.1 Pediatric Respiratory Disorders: IMCI Danger Signs and Cough Assessment, URI, Tonsillitis & Peritonsillar Abscess, Croup, Epiglottitis, Foreign Body, Bronchiolitis, Pneumonia, Pleural Effusion and Complications 27.2 Pediatric Cardiovascular & Collagen Disorders: Heart Sounds and Murmurs, Acyanotic and Cyanotic Congenital Heart Disease, Eisenmenger, Hypercyanotic Spells, Heart Failure, Rheumatic Fever, Hypertension, Endocarditis, Kawasaki, SLE, JIA, Dermatomyositis and Pediatric Resuscitation 27.3 Pediatric CNS Disorders: Febrile Seizures, Epilepsy Syndromes, Status Epilepticus, Meningitis and Encephalitis in Children, Cerebral Palsy, Hydrocephalus & Neural Tube Defects, Headache and Migraine, and Brain Tumors 27.4 Pediatric GI Disorders & Poisoning: Vomiting (Pyloric Stenosis, Atresias, Malrotation, Intussusception, GERD), Diarrhea and IMCI Rehydration Plans, Abdominal Pain, Constipation & Hirschsprung, Jaundice, Biliary Atresia & Choledochal Cyst, Hepatitis, Food Allergy, and Kerosene, Aspirin and INH Poisoning

28 Chapter 28: Pediatrics III: Genitourinary, Endocrine, Hematologic & Oncologic Disorders

28.1 Pediatric Genitourinary Disorders & Child Abuse: UTI and Vesicoureteral Reflux, Post-Streptococcal GN and Other Nephritides, Nephrotic Syndrome, AKI and HUS, CKD, Congenital Urogenital Anomalies, and Recognizing and Reporting Child Abuse 28.2 Pediatric Endocrine & Metabolic Disorders: Short Stature and Growth Hormone, Gigantism, Diabetes Insipidus, Congenital Hypothyroidism, Graves Disease & Goiter, Type 1 Diabetes and DKA, Congenital Adrenal Hyperplasia, Cushing Syndrome, Pheochromocytoma and Adrenal Crisis 28.3 Pediatric Hematology, Allergy & Immunology: Normal Hemogram and Immunoglobulins by Age, Anemias (Iron Deficiency, Thalassemia, G6PD, Spherocytosis, Aplastic), Bleeding Disorders (ITP, Hemophilia, vWD, DIC, Vitamin K), IgA Vasculitis, Rashes and Drug Reactions, Asthma, Allergic Rhinitis and Primary Immunodeficiencies 28.4 Pediatric Oncology & Genetics: Leukemias and Lymphomas, Retinoblastoma, Wilms Tumor, Neuroblastoma, Ewing Sarcoma and Osteosarcoma; Sex Chromosome and Autosomal Disorders, Inborn Errors of Metabolism and the Dysmorphic ("Odd-Looking") Child

29 Chapter 29: Preventive Medicine I: The Physician as Health Care Provider

29.1 The Physician as Health Care Provider I: Natural History of Disease, Disease Causation, Levels of Prevention and Primary Care Across the Clinical Rotations 29.2 The Physician as Health Care Provider II: The Filipino Family and Family Assessment Tools, Health Education and Promotion, Behavior Change Models and Geriatric Medicine 29.3 The Physician as Health Care Provider III: The Primary Health Care Concept (Alma-Ata, Astana, Philippine PHC) and Mental Health in Primary Care under RA 11036

30 Chapter 30: Preventive Medicine II: Philippine Health Care System & Community Medicine

30.1 The Philippine Health Care System: DOH Structure, Levels of Care and Referral, Devolution under RA 7160, the Universal Health Care Act (RA 11223), PhilHealth and YAKAP, and Leading Causes of Morbidity and Mortality 30.2 Epidemiology, Surveillance & Outbreaks: Measures of Disease Occurrence and Association, Rates, Endemic and Epidemic Levels, PIDSR and RA 11332 Notifiable Diseases, the Ten Steps of Outbreak Investigation and Epidemic Curves 30.3 DOH Programs & Environmental Sanitation: TB, Dengue, Rabies, Leprosy, Helminth and Other Disease Programs; the Sanitation Code (PD 856), Water Supply and Potability, Excreta and Solid Waste, Food Sanitation and Health Care Waste 30.4 Community Medicine: Principles of Public Health Administration and Program Planning, Vital Health Indices (Infant and Maternal Mortality), the Ecologic Concept of Health, Lifestyle and Non-Communicable Diseases, Health-Seeking Behavior and Traditional Medicine

31 Chapter 31: Preventive Medicine III: Manager, Researcher & Social Mobilizer

31.1 The Physician as Administrative Manager: Communication and Interpersonal Skills, Teamwork, Adult Learning, Occupational Health (RA 11058), Bioethics, Palliative Care, School Health, Organ Transplantation and Birth and Death Certificates 31.2 The Physician as Researcher I: The Research Process and Proposal, Research Ethics, Study Designs and Meta-Analysis, Demography and Vital Statistics, Evidence-Based Medicine and Quality Assurance 31.3 The Physician as Researcher II: Biostatistics (Data Types, Distributions, Central Tendency and Dispersion, Confidence Intervals, Hypothesis Testing and Test Selection) and Screening Tests (Validity, Predictive Values, Likelihood Ratios, Biases and Program Criteria) 31.4 The Physician as Social Mobilizer and Leader: Philippine Health Laws, Decrees and Executive Orders, Principles of Social Mobilization and Community Organizing, and Disaster Risk Reduction and Management in Health

32 Chapter 32: Pharmacology I: Principles, Cardiovascular & Nervous System Therapeutics

32.1 Pharmacology Foundations: The Pharmacology TOS, Pharmacokinetics, Drug Metabolism and Interactions, Pharmacodynamics, Adverse Drug Reactions and Monitoring, Autonomic Pharmacology, and Philippine Prescribing Rules 32.2 Cardiovascular Pharmacology I: Cardiac Arrest and ACLS Drugs, Bradycardia and Complete Heart Block, Antiarrhythmics, Anticoagulation in Atrial Fibrillation, Antianginals, ACS Therapy and Fibrinolysis, Pericarditis and Endocarditis Regimens 32.3 Cardiovascular Pharmacology II: Antihypertensives and Diuretics, Hypertensive Emergencies, Vasopressors and Inotropes in Shock, Heart Failure GDMT and Digoxin, and Lipid-Lowering Therapy 32.4 Nervous System Pharmacology I: Antiseizure Drugs and Status Epilepticus, Headache and Migraine, Vertigo, Stroke Thrombolysis and Secondary Prevention, Encephalopathy, Dementia, ADHD, Parkinson Disease and Movement Disorders, Raised Intracranial Pressure and CNS Infections

33 Chapter 33: Pharmacology II: Psychiatric, Respiratory & Genitourinary Therapeutics

33.1 Nervous System Pharmacology II: Antidepressants and Their Toxicity, Serotonin Syndrome, Anxiolytics and Hypnotics, Antipsychotics, EPS and NMS, Lithium and Mood Stabilizers, Sleep Disorders, Agitation and Alcohol Withdrawal 33.2 Respiratory Pharmacology: Cough and Colds, Allergic Rhinitis, Asthma (Controllers, Relievers, Exacerbations), COPD, Anti-TB Drugs, Antibiotics for Pneumonia and Bronchitis, and Lung Cancer Therapy 33.3 Genitourinary Pharmacology I: Antimicrobial Classes and Toxicities, and Drug Treatment of UTI, Pyelonephritis, Gonorrhea, Chlamydia, Syphilis, Genital Herpes, Genital Warts, PID, Vaginitis, Prostatitis and Orchitis 33.4 Genitourinary Pharmacology II: Kidney Stones, Nephrotic and Nephritic Disease, Drug Dosing in Kidney Disease and Hyperkalemia, Benign Prostatic Hyperplasia, Erectile Dysfunction, Renal Cell Carcinoma and Prostate Cancer Therapy

34 Chapter 34: Pharmacology III: Digestive, Endocrine, Skin & Musculoskeletal Therapeutics

34.1 Digestive Pharmacology: Portal Hypertension and Variceal Bleeding, Acid-Peptic Disease, H. pylori and GERD, Antiemetics, Laxatives and Antidiarrheals, Biliary and Pancreatic Disease, GI Infections and Parasites, Viral Hepatitis, C. difficile, Candidiasis and GI Cancer Chemotherapy 34.2 Endocrine Pharmacology I: Diabetes Mellitus Drugs (Metformin, Sulfonylureas, SGLT2 Inhibitors, GLP-1 Agonists, DPP-4 Inhibitors, Thiazolidinediones, Insulins), Choosing Therapy by Comorbidity, DKA and HHS, and Hypoglycemia 34.3 Endocrine Pharmacology II: Pituitary Disorders (GH Deficiency, Acromegaly, Prolactinoma, Diabetes Insipidus, Panhypopituitarism), Thyroid Drugs and Thyroid Storm, Calcium and Parathyroid Disorders, Adrenal Disorders and Corticosteroids 34.4 Cutaneous and Musculoskeletal Pharmacology: Cellulitis and Abscess, Drug-Induced Skin Reactions (SJS/TEN), Pain Management (Paracetamol, NSAIDs, Opioids), Osteoporosis, Rheumatoid Arthritis and Osteoarthritis, Septic and TB Arthritis, Gout, SLE and Psoriasis

35 Chapter 35: Surgery I: Basic Surgical Principles

35.1 Basic Surgical Principles I: The Surgery TOS, Fluids and Electrolytes, Acid-Base Balance, the Metabolic Response to Injury, Surgical Nutrition and Blood Transfusion 35.2 Basic Surgical Principles II: Shock and Surgical Critical Care, Hemorrhagic Shock and Massive Transfusion, ATLS Primary and Secondary Survey, Chest and Abdominal Trauma, Head and Spine Injury, Pelvic Fractures and Burns 35.3 Basic Surgical Principles III: Preoperative Assessment, Wound Healing, Surgical Infection and Asepsis, Postoperative Fever, Surgical Oncology, Immunology and Transplantation, Anesthesia and Patient Safety

36 Chapter 36: Surgery II: Abdomen, Breast & Hernia

36.1 Abdomen I: Esophagus (Hiatal Hernia, GERD, Achalasia, Caustic Injury, Barrett, Boerhaave, Mallory-Weiss, Cancer), Stomach and Duodenum (Peptic Ulcer Complications, Upper GI Bleeding, Gastric Cancer, GIST), Small Bowel (Obstruction, Ileus, Tumors, Typhoid and TB), Retroperitoneum and Abdominal Wall 36.2 Abdomen II: Gallstones, Cholecystitis, Choledocholithiasis and Cholangitis, Obstructive Jaundice, Liver (Cirrhosis, Portal Hypertension, Abscesses, Tumors and Hepatocellular Carcinoma), Pancreas (Acute and Chronic Pancreatitis, Pancreatic Cancer) and Spleen (Splenectomy, OPSI) 36.3 Abdomen III: Acute Appendicitis, Colonic Obstruction and Volvulus, Lower GI Bleeding, Diverticular Disease, Colorectal Polyps and Cancer, Hemorrhoids, Anal Fissure, Perianal Abscess and Fistula 36.4 Breast, Hernia and Skin and Soft Tissue: Benign Breast Masses, Breast Cancer Evaluation and Treatment, Groin and Abdominal Wall Hernias, Benign Skin and Soft-Tissue Tumors, Skin Cancers and Soft-Tissue Sarcoma

37 Chapter 37: Surgery III: Surgical Specialties

37.1 Head and Neck, Thyroid, Parathyroid, Endocrine and Bariatric Surgery and Otorhinolaryngology: Neck Masses and Head and Neck Cancer, Salivary Glands, Thyroid Nodules and Cancer, Goiter and Hyperthyroidism Surgery, Hyperparathyroidism, Adrenal Surgery, Bariatric Surgery, Nasal Polyps, Epistaxis, Vertigo, Hearing Loss and ENT Infections 37.2 Specialty I: Neurosurgery (Raised Intracranial Pressure and Herniation, Head Injury and Hematomas, Spontaneous Intracranial Hemorrhage, CNS and Peripheral Nerve Tumors, Spinal Cord Compression, Neurosurgical Infections) and Ophthalmology (Glaucoma, Cataract, Ophthalmic Emergencies) 37.3 Specialty II: Thoracic and Cardiovascular Surgery (Pleural Effusion and Empyema, Lung Cancer, Mediastinal Masses, Surgical Heart Disease, Aortic Aneurysm and Dissection, Peripheral Arterial and Venous Disease), Urology (Stones, Infections, Torsion, BPH, Urologic Tumors) and Gynecologic Surgery 37.4 Specialty III: Plastic and Reconstructive Surgery (Skin Grafts and Flaps, Cleft Lip and Palate, Facial Fractures, Hand Injuries), Orthopedics (Fractures, Dislocations, Bone and Joint Infections, Bone Tumors) and Pediatric Surgery (Hernias, CDH, Esophageal Atresia, Obstruction, Hirschsprung Disease, Neonatal Jaundice, Tumors)

38 Chapter 38: Medicine I: Cardiovascular, Digestive & Endocrine Medicine

38.1 Cardiovascular Medicine I: Hypertension and Secondary Causes, Dyslipidemia, Stable Angina and Acute Coronary Syndromes, Post-MI Complications, Heart Failure and Shock Syndromes 38.2 Cardiovascular Medicine II: Tachyarrhythmias and Bradyarrhythmias, Atrial Fibrillation, Sudden Cardiac Death and Brugada Syndrome, Cardiac Arrest, Valvular and Rheumatic Heart Disease, Infective Endocarditis, Myocarditis and Pericardial Disease 38.3 Gastroenterology and Hepatology: GERD and Peptic Ulcer Disease, Upper and Lower GI Bleeding, Diarrhea and GI Infections, Acute Pancreatitis and Biliary Disease, Viral Hepatitis, Cirrhosis and Portal Hypertension, Liver and GI Cancers 38.4 Endocrinology: Diabetes Mellitus Diagnosis, Treatment and Complications, DKA and HHS, Thyroid Disease, Pituitary Disorders, Adrenal Disorders (Cushing, Aldosteronism, Addison, Pheochromocytoma), Calcium and Parathyroid Disorders, Obesity and Metabolic Syndrome

39 Chapter 39: Medicine II: Hematology, Systemic Infections, Renal & Respiratory Medicine

39.1 Hematology, Immunology and Systemic Infections: Anemias (Iron Deficiency, Thalassemia, G6PD Deficiency, Megaloblastic, Hemolytic), Acute and Chronic Leukemias and Their Emergencies, Allergic Disorders, Dengue in Adults, COVID-19, Malaria and HIV/AIDS Opportunistic Infections 39.2 Nephrology: Acute Kidney Injury, Chronic Kidney Disease and Dialysis, Sodium and Potassium Disorders, Acid-Base Analysis, Urinary Tract Infections, Glomerular Diseases (Nephritic and Nephrotic), Kidney Stones, Renal Tumors and Sexually Transmitted Infections 39.3 Pulmonology and Critical Care: Acute Respiratory Failure and Oxygen Therapy, Bronchial Asthma, COPD, Community- and Hospital-Acquired Pneumonia, Pulmonary Tuberculosis and TB Infection, Pulmonary Embolism, Lung Cancer and ARDS

40 Chapter 40: Medicine III: Rheumatology, Dermatology, Neurology, Rehabilitation & Psychiatry

40.1 Rheumatology and Dermatology: Approach to Arthritis, Osteoarthritis, Rheumatoid Arthritis, Gout, Spondyloarthritis, SLE and Other Connective Tissue Diseases, Vasculitis and Myalgias, Bone Tumors, Common Skin Lesions, Skin Infections and Infestations, Eczema, Psoriasis, Severe Drug Eruptions and Skin Signs of Systemic Disease 40.2 Neurology and Rehabilitation Medicine: Stroke and TIA (Localization, Thrombolysis, Thrombectomy, Secondary Prevention), Intracranial Hemorrhage, Seizures and Status Epilepticus, Meningitis and Encephalitis, Tetanus and Rabies, Parkinsonism, Neuromuscular and Degenerative Diseases, Dementia, CNS Tumors, Post-Stroke Rehabilitation and Musculoskeletal Disorders 40.3 Psychiatry: Mental Status Examination, Depressive Disorders, Bipolar Disorder, Schizophrenia and Other Psychoses, Anxiety Disorders, OCD and Trauma-Related Disorders, Substance Use, and Acute Psychiatric Emergencies (Suicide Risk, Agitation, Withdrawal, Wernicke Encephalopathy)

38.2 Cardiovascular Medicine II: Tachyarrhythmias and Bradyarrhythmias, Atrial Fibrillation, Sudden Cardiac Death and Brugada Syndrome, Cardiac Arrest, Valvular and Rheumatic Heart Disease, Infective Endocarditis, Myocarditis and Pericardial Disease

Key Takeaways Explain This Topic AI

Any tachyarrhythmia with hypotension, shock, altered mental status, ischemic chest pain or acute heart failure needs synchronized cardioversion; stable regular narrow-complex SVT gets vagal maneuvers, then adenosine 6 mg then 12 mg.

AF with pre-excitation (WPW) must not be treated with AV nodal blockers; use procainamide or cardioversion.

Brugada syndrome (coved ST elevation in V1 to V2) causes sudden nocturnal death in young Southeast Asian men ("bangungot"); survivors need an ICD.

Patients with AF and moderate-to-severe rheumatic mitral stenosis or a mechanical valve are anticoagulated with warfarin, not a DOAC.

Endocarditis prophylaxis (amoxicillin 2 g before dental work that manipulates the gums) is limited to the highest-risk patients, such as those with prosthetic valves or prior endocarditis.

Last updated: October 2026

Why this area matters

Rheumatic heart disease remains a common cause of valve disease, atrial fibrillation and stroke in young Filipinos. "Bangungot" , the sudden death of young men during sleep, has been linked to Brugada syndrome . Tuberculous pericarditis is still seen. The PLE tests ECG recognition, the first treatment of each arrhythmia, murmurs, and the diagnosis of endocarditis and pericardial disease.

Approach to arrhythmias

First question: is the patient unstable? Signs are hypotension, shock, altered mental status , ischemic chest pain and acute heart failure .

Unstable tachycardia : synchronized cardioversion .

Unstable bradycardia : atropine 1 mg IV (repeat every 3 to 5 minutes, up to 3 mg), then transcutaneous pacing or a dopamine or epinephrine infusion .

Narrow-complex regular tachycardia (SVT):

usually AV nodal re-entry;

vagal maneuvers (modified Valsalva, carotid massage if no bruit), then adenosine 6 mg rapid IV push, then 12 mg ;

then a beta-blocker or calcium channel blocker;

catheter ablation for recurrence.

Atrial flutter: sawtooth flutter waves in II, III and aVF, often with 2:1 block at a ventricular rate of about 150 . Managed like AF (rate control, anticoagulation, cardioversion), and ablation is highly effective.

Wolff-Parkinson-White syndrome:

  • short PR , a delta wave and a wide QRS;
  • AF with pre-excitation gives an irregular, very fast wide-complex rhythm;

do not give AV nodal blockers (adenosine, beta-blockers, calcium channel blockers, digoxin), which can cause VF;

give procainamide or cardiovert, then ablate the pathway.

Wide-complex tachycardia:

  • treat as VT until proven otherwise, especially with structural heart disease;
  • stable VT: amiodarone 150 mg IV over 10 minutes (or procainamide), or elective cardioversion;

torsades de pointes : polymorphic VT with long QT, from drugs (macrolides, fluoroquinolones, antipsychotics, methadone, antiarrhythmics), hypokalemia and hypomagnesemia ; give IV magnesium sulfate 2 g and correct electrolytes, with overdrive pacing if needed.

Sinus tachycardia is a response to fever, pain, hypovolemia, anemia, hypoxia or thyrotoxicosis; treat the cause.

  • Cardiac Arrhythmias & Resuscitation Protocols
  • Atrioventricular (AV) Blocks

First-Degree AV Block: Constant prolongation of the PR interval ( > 0.20 seconds > 0.20\text{ seconds} > 0.20 seconds or > 5 > 5 > 5 small squares) with every P wave conducted to a QRS complex. Typically benign; observation without intervention.

Second-Degree AV Block, Mobitz Type I (Wenckebach): Progressive, gradual lengthening of the PR interval until a P wave fails to conduct (dropped QRS complex). The cycle then resets. Originates at the AV node; usually benign and reversible.

Second-Degree AV Block, Mobitz Type II: Fixed, constant PR intervals on conducted beats, with intermittent, unexpected non-conducted P waves. Originates below the AV node (His-Purkinje system) and carries high risk of progressing to complete block; indicates permanent pacemaker implantation.

Third-Degree (Complete) AV Block: Complete atrioventricular dissociation; regular atrial rate (P-P intervals) and independent regular slower ventricular rate (R-R intervals) with no temporal relationship between P waves and QRS complexes. Requires immediate temporary pacing and permanent pacemaker placement.

Atrial Fibrillation (AF)

Atrial fibrillation is characterized by chaotic, disorganized atrial electrical activity without distinct P waves, replaced by irregular fibrillatory waves and an "irregularly irregular" ventricular rhythm.

Rate versus Rhythm Control: Rate control (target resting heart rate < 110 bpm < 110\text{ bpm} < 110 bpm ) uses beta-blockers, non-dihydropyridine calcium channel blockers (diltiazem or verapamil; avoid in HFrEF), or digoxin. Rhythm control (antiarrhythmics like amiodarone, flecainide, propafenone, or direct-current cardioversion) is indicated for persistent symptoms, young patients, or heart failure precipitated by tachycardia.

Cardioversion Anticoagulation Rule: If AF duration is > 48 hours > 48\text{ hours} > 48 hours (or unknown), therapeutic anticoagulation is mandatory for at least 3 weeks prior to cardioversion and continued for at least 4 weeks post-procedure, unless transesophageal echocardiography (TEE) confirms absence of left atrial appendage thrombus.

Stroke Risk Stratification ( C H A 2 D S 2 − V A S c CHA_2DS_2-VASc C H A 2 ​ D S 2 ​ − V A S c Score):

  • Congestive heart failure: 1 point
  • Hypertension: 1 point
  • Age ≥ 75 \ge 75 ≥ 75 years: 2 points
  • Diabetes mellitus: 1 point
  • Stroke / TIA / Thromboembolism history: 2 points
  • Vascular disease (prior MI, PAD, aortic plaque): 1 point
  • Age 65-74 years: 1 point
  • Sex category (Female): 1 point

Decision Threshold: Score ≥ 2 \ge 2 ≥ 2 in men or ≥ 3 \ge 3 ≥ 3 in women mandates chronic oral anticoagulation. Direct Oral Anticoagulants (DOACs: Apixaban, Rivaroxaban, Dabigatran, Edoxaban) are preferred over Warfarin except in moderate-to-severe mitral stenosis or mechanical prosthetic heart valves.

ACLS Pulseless Arrest: Shockable Rhythms (VT / VF)

For pulseless Ventricular Tachycardia (pVT) and Ventricular Fibrillation (VF):

Initiate immediate high-quality cardiopulmonary resuscitation (CPR: rate 100-120/min, depth 2 to 2.4 inches, complete chest recoil, minimize interruptions).

Deliver immediate unsynchronized defibrillation (biphasic 120 − 200 J 120-200\text{ J} 120 − 200 J ; monophasic 360 J 360\text{ J} 360 J ).

Resume CPR immediately for 2 minutes without pausing for rhythm/pulse checks.

Administer Epinephrine 1 mg 1\text{ mg} 1 mg IV/IO every 3 to 5 minutes starting after the second unsynchronized shock.

If VT/VF is refractory after the third shock, administer Amiodarone ( 300 mg 300\text{ mg} 300 mg IV/IO bolus, second dose 150 mg 150\text{ mg} 150 mg ) or Lidocaine ( 1.0 to 1.5 mg/kg 1.0\text{ to }1.5\text{ mg/kg} 1.0 to 1.5 mg/kg first dose, then 0.5 to 0.75 mg/kg 0.5\text{ to }0.75\text{ mg/kg} 0.5 to 0.75 mg/kg ).

More on arrest and AF:

Non-shockable rhythms (asystole, PEA):

CPR with epinephrine as soon as possible ;

search for the reversible causes , the Hs and Ts : hypovolemia, hypoxia, hydrogen ion (acidosis), hypo- or hyperkalemia, hypothermia; tension pneumothorax, tamponade, toxins, and thrombosis (coronary or pulmonary).

AF in rheumatic mitral stenosis or with a mechanical valve: anticoagulate with warfarin (target INR 2 to 3, or 2.5 to 3.5 for mechanical mitral valves) , not DOACs.

New AF: check thyroid function, echo, electrolytes, and look for alcohol use ("holiday heart"), sleep apnea and valve disease.

Sudden cardiac death

Causes:

coronary artery disease (acute ischemia or scar-related VT): the most common cause in adults;

cardiomyopathies : dilated, and hypertrophic cardiomyopathy in young athletes (dynamic outflow murmur that increases with Valsalva and standing);

channelopathies : long QT syndrome (triggers include exercise, swimming, loud noises), Brugada syndrome and catecholaminergic VT;

WPW and commotio cordis.

Brugada syndrome:

a sodium channel (SCN5A) disorder, most common in young Southeast Asian men ;

the type 1 ECG shows coved ST elevation of 2 mm or more in V1 to V2 with a right bundle branch block pattern, which can be unmasked by fever or sodium channel blockers;

causes VF during sleep, matching the Filipino description of bangungot (sudden unexplained nocturnal death);

survivors of arrest and patients with arrhythmic syncope need an ICD ; treat fevers promptly and avoid triggering drugs.

Prevention: an ICD for survivors of VF or sustained VT without a reversible cause, and for primary prevention in selected cardiomyopathies.

Bystander CPR and early defibrillation (public AEDs) are the main determinants of survival.

  • Valvular and rheumatic heart disease
  • Valvular Heart Diseases

Valvular Lesion Primary Etiology Physical Exam & Murmur Characteristics Hemodynamic Hallmarks & Treatment

Aortic Stenosis (AS) Calcific degeneration (elderly), bicuspid valve (younger) Harsh crescendo-decrescendo systolic murmur at right 2nd intercostal space radiating to carotids; delayed/diminished carotid upstroke ( pulsus parvus et tardus ); soft/absent S 2 S_2 S 2 ​ Classic triad: Angina, Syncope, Dyspnea (SAD) ; transcatheter (TAVR) or surgical aortic valve replacement (SAVR) indicated when symptomatic or severe ( V m a x ≥ 4.0 m/s V_{max} \ge 4.0\text{ m/s} V ma x ​ ≥ 4.0 m/s , area < 1.0 cm 2 < 1.0\text{ cm}^2 < 1.0 cm 2 )

Aortic Regurgitation (AR) Aortic root dilation, bicuspid valve, infective endocarditis High-pitched, blowing decrescendo early diastolic murmur at left 3rd-4th intercostal space; widened pulse pressure ; bounding water-hammer pulse (Corrigan) Left ventricular volume overload; Austin Flint murmur; valve replacement before irreversible LV systolic dysfunction

Mitral Stenosis (MS) Rheumatic heart disease ( > 90 % > 90\% > 90% ) Opening snap (OS) followed by a low-pitched rumbling mid-diastolic murmur with presystolic accentuation, best heard at apex in left lateral decubitus with bell Elevated left atrial pressure, pulmonary venous hypertension, hemoptysis, high risk of atrial fibrillation; percutaneous mitral balloon commissurotomy (PMBC)

Mitral Regurgitation (MR) Primary (myxomatous prolapse, flail leaflet) or Secondary (ischemic LV remodeling) Blowing holosystolic (pansystolic) murmur at apex radiating to left axilla; hyperdynamic displaced apical impulse; soft S 1 S_1 S 1 ​ , prominent S 3 S_3 S 3 ​ Volume overload of left atrium and ventricle; surgical valve repair or replacement indicated for symptoms or LVEF ≤ 60 % \text{LVEF} \le 60\% LVEF ≤ 60% / LVESD ≥ 40 mm \ge 40\text{ mm} ≥ 40 mm

Chronic rheumatic heart disease:

follows repeated acute rheumatic fever (group A streptococcal pharyngitis), which is diagnosed by the Jones criteria (see microbiology);

mitral stenosis is the classic lesion, often with mitral regurgitation and aortic valve disease;

complications of mitral stenosis are atrial fibrillation , stroke , pulmonary hypertension , hemoptysis, hoarseness (Ortner syndrome) and decompensation in pregnancy ;

secondary prevention is benzathine penicillin G 1.2 million units IM every 3 to 4 weeks , for at least 10 years after the last attack and up to age 40 or longer when valve disease persists;

treated with percutaneous balloon mitral commissurotomy for suitable valves, or surgery.

Other valve lesions:

mitral valve prolapse : a mid-systolic click and late systolic murmur;

tricuspid regurgitation : a holosystolic murmur at the left lower sternal border that increases with inspiration (Carvallo sign), from pulmonary hypertension or endocarditis in people who inject drugs.

Dynamic auscultation: most right-sided murmurs increase with inspiration. Murmurs of HCM and MVP increase with Valsalva and standing (less preload), while most others decrease.

  • Infective endocarditis, myocarditis and pericardial disease
  • Infective Endocarditis & Pericardial Diseases
  • Modified Duke Criteria for Infective Endocarditis

Definite diagnosis requires 2 Major Criteria , 1 Major + 3 Minor Criteria , or 5 Minor Criteria :

Major Criteria:

Positive Blood Cultures: Typical microorganisms consistent with IE from 2 separate blood cultures ( Viridans streptococci , Streptococcus gallolyticus , Staphylococcus aureus , or enterococci), or persistently positive blood cultures, or single positive culture for Coxiella burnetii .

Evidence of Endocardial Involvement: Positive echocardiogram demonstrating oscillating intracardiac vegetation, myocardial abscess, new partial dehiscence of a prosthetic valve, or new valvular regurgitation.

Minor Criteria:

Predisposition (prosthetic valve, prior IE, structural heart disease, IV drug use).

Fever (temperature ≥ 38.0 ∘ C \ge 38.0^\circ\text{C} ≥ 38. 0 ∘ C ).

Vascular phenomena (major arterial emboli, septic pulmonary infarcts, mycotic aneurysm, intracranial hemorrhage, conjunctival hemorrhages, painless erythematous Janeway lesions on palms/soles).

Immunologic phenomena (glomerulonephritis, painful erythematous nodules on pads of digits called Osler nodes , retinal Roth spots , rheumatoid factor).

Microbiological evidence not meeting major criteria.

Acute Pericarditis versus Cardiac Tamponade

Acute Pericarditis: Presents with sharp, pleuritic retrosternal chest pain that improves sitting up and leaning forward and worsens when supine. Physical exam reveals a high-pitched superficial pericardial friction rub . ECG shows diffuse, concave-upward ST-segment elevation with concurrent PR-segment depression across multiple leads (with reciprocal PR elevation and ST depression in lead aVR). First-line treatment: NSAIDs (ibuprofen 600 − 800 mg 600-800\text{ mg} 600 − 800 mg TID) plus Colchicine ( 0.5 − 0.6 mg 0.5-0.6\text{ mg} 0.5 − 0.6 mg daily to BID) for 3 months to prevent recurrences.

Cardiac Tamponade: Accumulation of pericardial fluid under increased pressure impairing ventricular filling. Presents with Beck's Triad (hypotension, jugular venous distension, and muffled/distant heart sounds), tachycardia, and Pulsus Paradoxus (an abnormally large decline in systolic blood pressure of > 10 mmHg > 10\text{ mmHg} > 10 mmHg during inspiration). ECG reveals low QRS voltage and electrical alternans (beat-to-beat variation in QRS amplitude). Treatment: Emergent therapeutic pericardiocentesis or surgical pericardial window.

More on endocarditis:

Organisms:

  • Staphylococcus aureus : acute endocarditis, prosthetic valves, people who inject drugs (tricuspid valve);
  • viridans streptococci : subacute endocarditis on damaged (often rheumatic) valves after dental procedures;
  • enterococci : after genitourinary procedures;
  • Streptococcus gallolyticus (bovis) : needs a colonoscopy for colon cancer;

culture-negative : prior antibiotics, HACEK organisms, Coxiella , Bartonella .

Investigations: three sets of blood cultures from separate sites before antibiotics , then echocardiography (transesophageal for prosthetic valves or when the transthoracic study is negative but suspicion is high).

Treatment:

empiric vancomycin plus ceftriaxone (or gentamicin), then targeted therapy for 4 to 6 weeks ;

surgery for heart failure from valve dysfunction, uncontrolled infection (abscess, heart block), fungal endocarditis, or large vegetations (more than 10 mm) with embolism.

Prophylaxis:

only for highest-risk patients : prosthetic valves or repair material, previous endocarditis , unrepaired cyanotic congenital heart disease and cardiac transplant valvulopathy;

only before dental procedures that manipulate the gums or the tooth root area, or perforate the mucosa;

amoxicillin 2 g orally 30 to 60 minutes before (azithromycin or doxycycline if allergic; clindamycin is no longer recommended);

good oral hygiene matters more.

Myocarditis:

usually viral (coxsackie B, adenovirus, influenza, COVID-19 ), and rarely after mRNA vaccination in young men; also diphtheria toxin and drugs;

  • chest pain, arrhythmias or heart failure, with raised troponin and normal coronary arteries ;
  • cardiac MRI supports the diagnosis;

treated supportively (heart failure therapy), with no competitive sport for 3 to 6 months .

Pericarditis:

diagnosed by two of four : pleuritic chest pain relieved by sitting forward, a friction rub , diffuse ST elevation with PR depression , and a new effusion;

tuberculous pericarditis is a common cause of large effusions in the Philippines and is treated with anti-TB drugs.

Constrictive pericarditis:

a thick, rigid pericardium, often after TB or radiation;

raised JVP , Kussmaul sign (JVP rises on inspiration), a pericardial knock , ascites and edema, and pericardial calcification ;

treated by pericardiectomy .